Sarasin & Partners’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-47,495
Closed -$1.01M 110
2019
Q4
$1.01M Hold
47,495
0.02% 116
2019
Q3
$1.09M Hold
47,495
0.02% 118
2019
Q2
$1.15M Hold
47,495
0.02% 118
2019
Q1
$616K Hold
47,495
0.01% 111
2018
Q4
$715K Sell
47,495
-9
-0% -$233 0.02% 109
2018
Q3
$1.87M Buy
+47,504
New +$2.14M 0.04% 105

Other funds holding ADNT

Sarasin & Partners's ADNT Position: Q1 2020 in Review

Sarasin & Partners sold out of Adient (ADNT) in Q1 2020, closing a stake of 47,495 shares — an estimated $1.01M sold.

Sarasin & Partners first reported a position in ADNT in Q3 2018 and held it in 6 quarters. The position peaked at $1.87M in Q3 2018. 284 funds tracked by Wall St. Rank hold ADNT as of Q1 2020.

  • Sarasin & Partners reported no remaining Adient position as of Q1 2020 after selling out during the quarter.
  • Sarasin & Partners sold 47,495 Adient shares in Q1 2020, an estimated $1.01M.
  • Sarasin & Partners first reported a position in Adient in Q3 2018 and held it in 6 quarters.
  • Sarasin & Partners's Adient position peaked at $1.87M in Q3 2018.
  • 284 funds tracked by Wall St. Rank held Adient as of Q1 2020.

Based on Sarasin & Partners's 13F filing for Q1 2020, filed 30 Apr 2020.